Global Synthetic Viral Controls Market 2023 by Company, Regions, Type and Application, Forecast to 2029

March 2023 | 114 pages | ID: G8F55AE6A2B5EN
GlobalInfoResearch

Abstracts

According to our latest research, the global Synthetic Viral Controls market size will reach USD million in 2029, growing at a CAGR of % over the analysis period.

Controls based on viral nucleic acids extracted from either an infected patient or from live virus propagated in cell culture have safety and security concerns.

The Synthetic Viral Controls market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation

Synthetic Viral Controls market is split by Type and by Application. For the period 2023-2029, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

• Monkeypox Controls
• SARS-COV-2 CONTROLS
• Respiratory Virus Controls

Market segment by Application, can be divided into

• Child
• Teenager
• Youth
• Middle-Aged
• Elder
• Others

Market segment by players, this report covers

• Twist Bioscience
• Vector Biolabs
• Premade Lentivirus Particles
• Telesis Bio
• Thermo Fisher Scientific
• Sigma Aldrich
• Antibody Engineering
• Amyris
• Precigen
• Ginkgo Bioworks
• Codexis
• Impossible Foods
• National Resilience
• ElevateBio
• Insitro
• Apeel Sciences

Market segment by regions, regional analysis covers

• North America
• Europe
• Asia-Pacific (China, Japan, South Korea, Rest of Asia-Pacific)
• South America
• Middle East & Africa

The content of the study subjects, includes a total of 8 chapters:

Chapter 1, to describe Synthetic Viral Controls product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Synthetic Viral Controls, with recent developments and future plans

Chapter 3, the Synthetic Viral Controls competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4, to break the market size data at the region level, with key companies in the key region and Synthetic Viral Controls market forecast, by regions, with revenue, from 2023 to 2029.

Chapter 5 and 6, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2023 to 2029.

Chapter 7 and 8, to describe Synthetic Viral Controls research findings and conclusion, appendix and data source.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope of Synthetic Viral Controls
1.2 Classification of Synthetic Viral Controls by Type
  1.2.1 Overview: Global Synthetic Viral Controls Market Size by Type: 2022 Versus 2028
  1.2.2 Global Synthetic Viral Controls Revenue Market Share by Type in 2029
  1.2.3 Monkeypox Controls
  1.2.4 SARS-COV-2 CONTROLS
  1.2.5 Respiratory Virus Controls
1.3 Global Synthetic Viral Controls Market by Application
  1.3.1 Overview: Global Synthetic Viral Controls Market Size by Application: 2023 Versus 2029
  1.3.2 Child
  1.3.3 Teenager
  1.3.4 Youth
  1.3.5 Middle-Aged
  1.3.6 Elder
  1.3.7 Others
1.4 Global Synthetic Viral Controls Market Size & Forecast
1.5 Market Drivers, Restraints and Trends
  1.5.1 Synthetic Viral Controls Market Drivers
  1.5.2 Synthetic Viral Controls Market Restraints
  1.5.3 Synthetic Viral Controls Trends Analysis

2 COMPANY PROFILES

2.1 Twist Bioscience
  2.1.1 Twist Bioscience Details
  2.1.2 Twist Bioscience Major Business
  2.1.3 Twist Bioscience Synthetic Viral Controls Product and Solutions
  2.1.4 Twist Bioscience Recent Developments and Future Plans
2.2 Vector Biolabs
  2.2.1 Vector Biolabs Details
  2.2.2 Vector Biolabs Major Business
  2.2.3 Vector Biolabs Synthetic Viral Controls Product and Solutions
  2.2.4 Vector Biolabs Recent Developments and Future Plans
2.3 Premade Lentivirus Particles
  2.3.1 Premade Lentivirus Particles Details
  2.3.2 Premade Lentivirus Particles Major Business
  2.3.3 Premade Lentivirus Particles Synthetic Viral Controls Product and Solutions
  2.3.4 Premade Lentivirus Particles Recent Developments and Future Plans
2.4 Telesis Bio
  2.4.1 Telesis Bio Details
  2.4.2 Telesis Bio Major Business
  2.4.3 Telesis Bio Synthetic Viral Controls Product and Solutions
  2.4.4 Telesis Bio Recent Developments and Future Plans
2.5 Thermo Fisher Scientific
  2.5.1 Thermo Fisher Scientific Details
  2.5.2 Thermo Fisher Scientific Major Business
  2.5.3 Thermo Fisher Scientific Synthetic Viral Controls Product and Solutions
  2.5.4 Thermo Fisher Scientific Recent Developments and Future Plans
2.6 Sigma Aldrich
  2.6.1 Sigma Aldrich Details
  2.6.2 Sigma Aldrich Major Business
  2.6.3 Sigma Aldrich Synthetic Viral Controls Product and Solutions
  2.6.4 Sigma Aldrich Recent Developments and Future Plans
2.7 Antibody Engineering
  2.7.1 Antibody Engineering Details
  2.7.2 Antibody Engineering Major Business
  2.7.3 Antibody Engineering Synthetic Viral Controls Product and Solutions
  2.7.4 Antibody Engineering Recent Developments and Future Plans
2.8 Amyris
  2.8.1 Amyris Details
  2.8.2 Amyris Major Business
  2.8.3 Amyris Synthetic Viral Controls Product and Solutions
  2.8.4 Amyris Recent Developments and Future Plans
2.9 Precigen
  2.9.1 Precigen Details
  2.9.2 Precigen Major Business
  2.9.3 Precigen Synthetic Viral Controls Product and Solutions
  2.9.4 Precigen Recent Developments and Future Plans
2.10 Ginkgo Bioworks
  2.10.1 Ginkgo Bioworks Details
  2.10.2 Ginkgo Bioworks Major Business
  2.10.3 Ginkgo Bioworks Synthetic Viral Controls Product and Solutions
  2.10.4 Ginkgo Bioworks Recent Developments and Future Plans
2.11 Codexis
  2.11.1 Codexis Details
  2.11.2 Codexis Major Business
  2.11.3 Codexis Synthetic Viral Controls Product and Solutions
  2.11.4 Codexis Recent Developments and Future Plans
2.12 Impossible Foods
  2.12.1 Impossible Foods Details
  2.12.2 Impossible Foods Major Business
  2.12.3 Impossible Foods Synthetic Viral Controls Product and Solutions
  2.12.4 Impossible Foods Recent Developments and Future Plans
2.13 National Resilience
  2.13.1 National Resilience Details
  2.13.2 National Resilience Major Business
  2.13.3 National Resilience Synthetic Viral Controls Product and Solutions
  2.13.4 National Resilience Recent Developments and Future Plans
2.14 ElevateBio
  2.14.1 ElevateBio Details
  2.14.2 ElevateBio Major Business
  2.14.3 ElevateBio Synthetic Viral Controls Product and Solutions
  2.14.4 ElevateBio Recent Developments and Future Plans
2.15 Insitro
  2.15.1 Insitro Details
  2.15.2 Insitro Major Business
  2.15.3 Insitro Synthetic Viral Controls Product and Solutions
  2.15.4 Insitro Recent Developments and Future Plans
2.16 Apeel Sciences
  2.16.1 Apeel Sciences Details
  2.16.2 Apeel Sciences Major Business
  2.16.3 Apeel Sciences Synthetic Viral Controls Product and Solutions
  2.16.4 Apeel Sciences Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Synthetic Viral Controls Revenue and Share by Players (2023 & 2029)
3.2 Synthetic Viral Controls Players Head Office, Products and Services Provided
3.3 Synthetic Viral Controls Mergers & Acquisitions
3.4 Synthetic Viral Controls New Entrants and Expansion Plans

4 GLOBAL SYNTHETIC VIRAL CONTROLS FORECAST BY REGION

4.1 Global Synthetic Viral Controls Market Size by Region: 2023 VS 2029
4.2 Global Synthetic Viral Controls Market Size by Region, (2023-2029)
4.3 North America
  4.3.1 Key Companies of Synthetic Viral Controls in North America
  4.3.2 Current Situation and Forecast of Synthetic Viral Controls in North America
  4.3.3 North America Synthetic Viral Controls Market Size and Prospect (2023-2029)
4.4 Europe
  4.4.1 Key Companies of Synthetic Viral Controls in Europe
  4.4.2 Current Situation and Forecast of Synthetic Viral Controls in Europe
  4.4.3 Europe Synthetic Viral Controls Market Size and Prospect (2023-2029)
4.5 Asia-Pacific
  4.5.1 Key Companies of Synthetic Viral Controls in Asia-Pacific
  4.5.2 Current Situation and Forecast of Synthetic Viral Controls in Asia-Pacific
  4.5.3 Asia-Pacific Synthetic Viral Controls Market Size and Prospect (2023-2029)
  4.5.4 China
  4.5.5 Japan
  4.5.6 South Korea
4.6 South America
  4.6.1 Key Companies of Synthetic Viral Controls in South America
  4.6.2 Current Situation and Forecast of Synthetic Viral Controls in South America
  4.6.3 South America Synthetic Viral Controls Market Size and Prospect (2023-2029)
4.7 Middle East & Africa
  4.7.1 Key Companies of Synthetic Viral Controls in Middle East & Africa
  4.7.2 Current Situation and Forecast of Synthetic Viral Controls in Middle East & Africa
  4.7.3 Middle East & Africa Synthetic Viral Controls Market Size and Prospect (2023-2029)

5 MARKET SIZE SEGMENT BY TYPE

5.1 Global Synthetic Viral Controls Market Forecast by Type (2023-2029)
5.2 Global Synthetic Viral Controls Market Share Forecast by Type (2023-2029)

6 MARKET SIZE SEGMENT BY APPLICATION

6.1 Global Synthetic Viral Controls Market Forecast by Application (2023-2029)
6.2 Global Synthetic Viral Controls Market Share Forecast by Application (2023-2029)

7 RESEARCH FINDINGS AND CONCLUSION

8 APPENDIX

8.1 Methodology
8.2 Research Process and Data Source
8.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Synthetic Viral Controls Revenue by Type, (USD Million), 2023 VS 2029
Table 2. Global Synthetic Viral Controls Revenue by Application, (USD Million), 2023 VS 2029
Table 3. Twist Bioscience Corporate Information, Head Office, and Major Competitors
Table 4. Twist Bioscience Major Business
Table 5. Twist Bioscience Synthetic Viral Controls Product and Solutions
Table 6. Vector Biolabs Corporate Information, Head Office, and Major Competitors
Table 7. Vector Biolabs Major Business
Table 8. Vector Biolabs Synthetic Viral Controls Product and Solutions
Table 9. Premade Lentivirus Particles Corporate Information, Head Office, and Major Competitors
Table 10. Premade Lentivirus Particles Major Business
Table 11. Premade Lentivirus Particles Synthetic Viral Controls Product and Solutions
Table 12. Telesis Bio Corporate Information, Head Office, and Major Competitors
Table 13. Telesis Bio Major Business
Table 14. Telesis Bio Synthetic Viral Controls Product and Solutions
Table 15. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 16. Thermo Fisher Scientific Major Business
Table 17. Thermo Fisher Scientific Synthetic Viral Controls Product and Solutions
Table 18. Sigma Aldrich Corporate Information, Head Office, and Major Competitors
Table 19. Sigma Aldrich Major Business
Table 20. Sigma Aldrich Synthetic Viral Controls Product and Solutions
Table 21. Antibody Engineering Corporate Information, Head Office, and Major Competitors
Table 22. Antibody Engineering Major Business
Table 23. Antibody Engineering Synthetic Viral Controls Product and Solutions
Table 24. Amyris Corporate Information, Head Office, and Major Competitors
Table 25. Amyris Major Business
Table 26. Amyris Synthetic Viral Controls Product and Solutions
Table 27. Precigen Corporate Information, Head Office, and Major Competitors
Table 28. Precigen Major Business
Table 29. Precigen Synthetic Viral Controls Product and Solutions
Table 30. Ginkgo Bioworks Corporate Information, Head Office, and Major Competitors
Table 31. Ginkgo Bioworks Major Business
Table 32. Ginkgo Bioworks Synthetic Viral Controls Product and Solutions
Table 33. Codexis Corporate Information, Head Office, and Major Competitors
Table 34. Codexis Major Business
Table 35. Codexis Synthetic Viral Controls Product and Solutions
Table 36. Impossible Foods Corporate Information, Head Office, and Major Competitors
Table 37. Impossible Foods Major Business
Table 38. Impossible Foods Synthetic Viral Controls Product and Solutions
Table 39. National Resilience Corporate Information, Head Office, and Major Competitors
Table 40. National Resilience Major Business
Table 41. National Resilience Synthetic Viral Controls Product and Solutions
Table 42. ElevateBio Corporate Information, Head Office, and Major Competitors
Table 43. ElevateBio Major Business
Table 44. ElevateBio Synthetic Viral Controls Product and Solutions
Table 45. Insitro Corporate Information, Head Office, and Major Competitors
Table 46. Insitro Major Business
Table 47. Insitro Synthetic Viral Controls Product and Solutions
Table 48. Apeel Sciences Corporate Information, Head Office, and Major Competitors
Table 49. Apeel Sciences Major Business
Table 50. Apeel Sciences Synthetic Viral Controls Product and Solutions
Table 51. Global Synthetic Viral Controls Revenue (USD Million) by Players (2023 & 2029)
Table 52. Global Synthetic Viral Controls Revenue Share by Players (2023 & 2029)
Table 53. Synthetic Viral Controls Players Head Office, Products and Services Provided
Table 54. Synthetic Viral Controls Mergers & Acquisitions in the Past Five Years
Table 55. Synthetic Viral Controls New Entrants and Expansion Plans
Table 56. Global Market Synthetic Viral Controls Revenue (USD Million) Comparison by Region (2023 VS 2029)
Table 57. Global Synthetic Viral Controls Revenue Market Share by Region (2023-2029)
Table 58. Key Companies of Synthetic Viral Controls in North America
Table 59. Current Situation and Forecast of Synthetic Viral Controls in North America
Table 60. Key Companies of Synthetic Viral Controls in Europe
Table 61. Current Situation and Forecast of Synthetic Viral Controls in Europe
Table 62. Key Companies of Synthetic Viral Controls in Asia-Pacific
Table 63. Current Situation and Forecast of Synthetic Viral Controls in Asia-Pacific
Table 64. Key Companies of Synthetic Viral Controls in China
Table 65. Key Companies of Synthetic Viral Controls in Japan
Table 66. Key Companies of Synthetic Viral Controls in South Korea
Table 67. Key Companies of Synthetic Viral Controls in South America
Table 68. Current Situation and Forecast of Synthetic Viral Controls in South America
Table 69. Key Companies of Synthetic Viral Controls in Middle East & Africa
Table 70. Current Situation and Forecast of Synthetic Viral Controls in Middle East & Africa
Table 71. Global Synthetic Viral Controls Revenue Forecast by Type (2023-2029)
Table 72. Global Synthetic Viral Controls Revenue Forecast by Application (2023-2029)

List Of Figures

LIST OF FIGURES

Figure 1. Synthetic Viral Controls Picture
Figure 2. Global Synthetic Viral Controls Revenue Market Share by Type in 2029
Figure 3. Monkeypox Controls
Figure 4. SARS-COV-2 CONTROLS
Figure 5. Respiratory Virus Controls
Figure 6. Synthetic Viral Controls Revenue Market Share by Application in 2029
Figure 7. Child Picture
Figure 8. Teenager Picture
Figure 9. Youth Picture
Figure 10. Middle-Aged Picture
Figure 11. Elder Picture
Figure 12. Others Picture
Figure 13. Global Synthetic Viral Controls Market Size, (USD Million): 2023 VS 2029
Figure 14. Global Synthetic Viral Controls Revenue and Forecast (2023-2029) & (USD Million)
Figure 15. Synthetic Viral Controls Market Drivers
Figure 16. Synthetic Viral Controls Market Restraints
Figure 17. Synthetic Viral Controls Market Trends
Figure 18. Twist Bioscience Recent Developments and Future Plans
Figure 19. Vector Biolabs Recent Developments and Future Plans
Figure 20. Premade Lentivirus Particles Recent Developments and Future Plans
Figure 21. Telesis Bio Recent Developments and Future Plans
Figure 22. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 23. Sigma Aldrich Recent Developments and Future Plans
Figure 24. Antibody Engineering Recent Developments and Future Plans
Figure 25. Amyris Recent Developments and Future Plans
Figure 26. Precigen Recent Developments and Future Plans
Figure 27. Ginkgo Bioworks Recent Developments and Future Plans
Figure 28. Codexis Recent Developments and Future Plans
Figure 29. Impossible Foods Recent Developments and Future Plans
Figure 30. National Resilience Recent Developments and Future Plans
Figure 31. ElevateBio Recent Developments and Future Plans
Figure 32. Insitro Recent Developments and Future Plans
Figure 33. Apeel Sciences Recent Developments and Future Plans
Figure 34. Global Synthetic Viral Controls Revenue Market Share by Region (2023-2029)
Figure 35. Global Synthetic Viral Controls Revenue Market Share by Region in 2029
Figure 36. North America Synthetic Viral Controls Revenue (USD Million) and Growth Rate (2023-2029)
Figure 37. Europe Synthetic Viral Controls Revenue (USD Million) and Growth Rate (2023-2029)
Figure 38. Asia-Pacific Synthetic Viral Controls Revenue (USD Million) and Growth Rate (2023-2029)
Figure 39. South America Synthetic Viral Controls Revenue (USD Million) and Growth Rate (2023-2029)
Figure 40. Middle East & Africa Synthetic Viral Controls Revenue (USD Million) and Growth Rate (2023-2029)
Figure 41. Global Synthetic Viral Controls Market Share Forecast by Type (2023-2029)
Figure 42. Global Synthetic Viral Controls Market Share Forecast by Application (2023-2029)
Figure 43. Methodology
Figure 44. Research Process and Data Source